News

St. Jude Medical, Inc., a global medical device company, announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility™ Ablation Catheter, a new ablation technology used by electrophysiologists for the treatment of cardiac...

Trial Examines Safety of Full-Body MRI Scans on ICDs, including DX Technology   LAKE OSWEGO, Oregon, January 21, 2015 - BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced today that Phase C of its ProMRI®...

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the first enrollments in its prospective, multi-center, international Reduce-TE Pilot study (Reduction of AF Ablation Induced Thrombo-Embolic Incidence). The...

Stereotaxis, Inc. and Princess Grace Hospital of Monaco announced the results of a recent clinical study conducted in Europe, which represent significant findings in terms of the Stereotaxis remote magnetic navigation platform's success in...

Apama Medical, Inc., a privately held medical device company focused on the development of next-generation atrial fibrillation technologies, announced raising $11.0M in the first tranche of its $17.5M Series B financing. Apama Medical is a...

Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, and Tucson Medical Center, Tucson, Arizona's locally governed nonprofit regional hospital since 1944, announced that they have teamed up...

Daiichi Sankyo Company, Limited (Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) has approved SAVAYSA™ (edoxaban) Tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of stroke and systemic...

St. Jude Medical, Inc., a global medical device company, announced the first patient enrollment in the STAR-VT (Substrate Targeted Ablation using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia) clinical...

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Arctic Front Advance(TM) cryoballoon as a first-line treatment for atrial fibrillation (AF) patients....

Stereotaxis, Inc., a leading provider of innovative technologies for the treatment of cardiac arrhythmias, announced that more than 75,000 patient cases have been completed with its remote magnetic navigation technology. The Company also...